BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35941113)

  • 21. NMR in metabolomics and natural products research: two sides of the same coin.
    Robinette SL; Brüschweiler R; Schroeder FC; Edison AS
    Acc Chem Res; 2012 Feb; 45(2):288-97. PubMed ID: 21888316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in decomposing complex metabolite mixtures using substructure- and network-based computational metabolomics approaches.
    Beniddir MA; Kang KB; Genta-Jouve G; Huber F; Rogers S; van der Hooft JJJ
    Nat Prod Rep; 2021 Nov; 38(11):1967-1993. PubMed ID: 34821250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Unknown Metabolomics Mixture Compounds by Combining NMR, MS, and Cheminformatics.
    Leggett A; Wang C; Li DW; Somogyi A; Bruschweiler-Li L; Brüschweiler R
    Methods Enzymol; 2019; 615():407-422. PubMed ID: 30638535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenges, progress and promises of metabolite annotation for LC-MS-based metabolomics.
    Chaleckis R; Meister I; Zhang P; Wheelock CE
    Curr Opin Biotechnol; 2019 Feb; 55():44-50. PubMed ID: 30138778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STRATEGIES AND CHALLENGES IN METHOD DEVELOPMENT AND VALIDATION FOR THE ABSOLUTE QUANTIFICATION OF ENDOGENOUS BIOMARKER METABOLITES USING LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY.
    Khamis MM; Adamko DJ; El-Aneed A
    Mass Spectrom Rev; 2021 Jan; 40(1):31-52. PubMed ID: 31617245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolite identification for mass spectrometry-based metabolomics using multiple types of correlated ion information.
    Lynn KS; Cheng ML; Chen YR; Hsu C; Chen A; Lih TM; Chang HY; Huang CJ; Shiao MS; Pan WH; Sung TY; Hsu WL
    Anal Chem; 2015 Feb; 87(4):2143-51. PubMed ID: 25543920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two elephants in the room: new hybrid nuclear magnetic resonance and mass spectrometry approaches for metabolomics.
    Bingol K; Brüschweiler R
    Curr Opin Clin Nutr Metab Care; 2015 Sep; 18(5):471-7. PubMed ID: 26154280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A strategy for sensitive, large scale quantitative metabolomics.
    Liu X; Ser Z; Cluntun AA; Mentch SJ; Locasale JW
    J Vis Exp; 2014 May; (87):. PubMed ID: 24894601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Native mass spectrometry-based metabolomics identifies metal-binding compounds.
    Aron AT; Petras D; Schmid R; Gauglitz JM; Büttel I; Antelo L; Zhi H; Nuccio SP; Saak CC; Malarney KP; Thines E; Dutton RJ; Aluwihare LI; Raffatellu M; Dorrestein PC
    Nat Chem; 2022 Jan; 14(1):100-109. PubMed ID: 34795435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MS
    Folberth J; Begemann K; Jöhren O; Schwaninger M; Othman A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 May; 1145():122105. PubMed ID: 32305706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advanced tandem mass spectrometry in metabolomics and lipidomics-methods and applications.
    Heiles S
    Anal Bioanal Chem; 2021 Oct; 413(24):5927-5948. PubMed ID: 34142202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overview of Tandem Mass Spectral and Metabolite Databases for Metabolite Identification in Metabolomics.
    Yi Z; Zhu ZJ
    Methods Mol Biol; 2020; 2104():139-148. PubMed ID: 31953816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Challenges and emergent solutions for LC-MS/MS based untargeted metabolomics in diseases.
    Cui L; Lu H; Lee YH
    Mass Spectrom Rev; 2018 Nov; 37(6):772-792. PubMed ID: 29486047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LC-MS/MS-Based Metabolomics for Cell Cultures.
    Artati A; Prehn C; Adamski J
    Methods Mol Biol; 2019; 1994():119-130. PubMed ID: 31124109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twins derivatization-based LC-MS: a promising quantitative tool for metabolomic analysis.
    Li W; Zhang Z; Xu F
    Bioanalysis; 2018 Aug; 10(15):1161-1163. PubMed ID: 30033740
    [No Abstract]   [Full Text] [Related]  

  • 36. An integrated metabolomics workflow for the quantification of sulfur pathway intermediates employing thiol protection with N-ethyl maleimide and hydrophilic interaction liquid chromatography tandem mass spectrometry.
    Ortmayr K; Schwaiger M; Hann S; Koellensperger G
    Analyst; 2015 Nov; 140(22):7687-95. PubMed ID: 26451393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research.
    Emwas AH
    Methods Mol Biol; 2015; 1277():161-93. PubMed ID: 25677154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-sensitive liquid chromatography-tandem mass spectrometry-based chiral metabolic profiling focusing on amino acids and related metabolites.
    Nakano Y; Taniguchi M; Fukusaki E
    J Biosci Bioeng; 2019 Apr; 127(4):520-527. PubMed ID: 30563742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional genomics of novel secondary metabolites from diverse cyanobacteria using untargeted metabolomics.
    Baran R; Ivanova NN; Jose N; Garcia-Pichel F; Kyrpides NC; Gugger M; Northen TR
    Mar Drugs; 2013 Sep; 11(10):3617-31. PubMed ID: 24084783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying Metabolic Perturbations and Toxic Effects of
    Zhang P; Wang S; He Y; Xu Y; Shi D; Yang F; Yu W; Zhu W; He L
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31683916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.